
|Articles|April 14, 2020
American College of Radiology Updates Breast Cancer Screening Appropriateness Criteria
Author(s)Whitney J. Palmer
Eight recommendations released for imaging women post-mastectomy and breast reconstruction.
Advertisement
The American College of Radiology (ACR) has released updated appropriateness criteria
Recurrence rates of breast cancer post-mastectomy are reported to be between 1 percent-to-2 percent. Clinical evaluation is critical for any post-mastectomy symptoms, including the appropriate use of imaging. These are the ACR’s recommendations:
- Imaging is usually not appropriate for a woman who underwent a mastectomy for breast cancer treatment but did not receive reconstruction.
- Mammography or digital breast tomosynthesis (DBT) may be appropriate for breast cancer screening in women with breast cancer history who underwent autologous breast reconstruction with or without implants.
- Imaging is usually not appropriate for women with a breast cancer history who received breast implant reconstruction.
- Imaging usually isn’t appropriate for high-risk women with no breast reconstruction who received a bilateral, prophylactic mastectomy.
- Imaging usually isn’t appropriate for high-risk women with autologous breast reconstruction who underwent a bilateral prophylactic mastectomy.
- Imaging usually isn’t appropriate for high-risk women with breast implant reconstruction who received a bilateral prophylactic mastectomy.
- Breast ultrasound as an initial imaging strategy is usually appropriate for women with a palpable lump or clinically significant pain on the side of a mastectomy that hasn’t had reconstruction.
- Breast ultrasound as an initial imaging strategy is usually appropriate for women with a palpable lump or clinically significant pain on the side of the mastectomy with either autologous or implant reconstruction.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Molecular Imaging in Focus: SNMMI: Can a New Total Body PET Scanner Slash Scan Times and Bolster Sensitivity?
2
Molecular Imaging in Focus: PSMA PET Radiotracers and Urinary Radioactivity: What Head-to-Head Prospective Multicenter Research Reveals
3
FDA Clears AI Software for Automated Contouring in Radiation Oncology
4
Mammography Study Shows Impact of AI-Powered Slab Reconstruction with DBT
5















